Head Lice Clinical Trial
Official title:
A Randomised, Assessor Blind, Parallel Group, Comparative Trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion®, NeutraLice Advance® and Moov Head Lice Solution®) After a Single Application
The purpose of this study is to compare the ovicidal activity of three head lice treatment
products.
The study population will consist of Queensland primary school-aged children (Grades 1 - 7)
who have at least 20 live eggs on the hair and who have not used any head lice product in
the four weeks prior to the study.
Enrollment will continue to achieve 30 subjects in each treatment group (total of 90
subjects).
Subjects will be examined for the presence of head louse eggs. Those subjects who have at
least 20 live eggs will be randomised into one of 3 treatment groups: NeutraLice Lotion,
NeutraLice Advance or Moov Head Lice Solution treatment groups.
Pre-treatment: 10 eggs will be removed from the head by cutting the single hair with the
live egg attached, before the treatment.
Treatment: The subject will then receive a single treatment application according to
manufacturers instructions. Then the treatment will be washed from the hair as per the
manufacturer's instructions.
Post-treatment: At least 10 treated (live) eggs will be removed from the head by cutting the
single hair with the egg attached, after the treatment.
All of the eggs will be held in an incubator for 14 days. The proportion of eggs which hatch
after 14 days will be compared for the pre-treatment and post-treatment eggs. Demographic
data will be collected for each subject (hair type, hair colour, hair length, subject age,
subject sex) to investigate the affect of hair type on ovicidal efficacy.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00988533 -
A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age
|
Phase 1 | |
| Completed |
NCT00672971 -
Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice
|
N/A | |
| Completed |
NCT00858481 -
A Pilot Dose Ranging Study of Spinosad Creme Rinse
|
Phase 2 | |
| Completed |
NCT03301649 -
Clinical Endpoint Study of Ivermectin 0.5% Lotion
|
Phase 3 | |
| Completed |
NCT00994422 -
Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
|
Phase 2 | |
| Completed |
NCT03337490 -
A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice
|
Phase 3 | |
| Completed |
NCT06333054 -
Safety and Efficacy of a Head Lice Shampoo
|
N/A | |
| Completed |
NCT02213055 -
Pediatric Head Lice Study Product Comparison
|
Phase 2 | |
| Completed |
NCT02974088 -
Neem Lotion With Combing for Lice
|
Phase 2 | |
| Recruiting |
NCT05379114 -
Comparative Study for the Evaluation of a New Medical Device on the Treatment of Head Lice Infestation
|
N/A | |
| Completed |
NCT03617926 -
A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.
|
N/A | |
| Completed |
NCT01803581 -
A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice
|
N/A | |
| Completed |
NCT01068158 -
A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
|
Phase 3 | |
| Completed |
NCT01066585 -
A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation
|
Phase 3 | |
| Completed |
NCT00857935 -
A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse
|
Phase 2 | |
| Completed |
NCT00301340 -
Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice
|
Phase 3 | |
| Completed |
NCT02062073 -
Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion
|
Phase 1 | |
| Completed |
NCT02061813 -
Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion
|
Phase 1 | |
| Completed |
NCT00605956 -
NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00301327 -
Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice.
|
Phase 3 |